• Indonesian Property Companies in Focus: Ciputra Development

    Ciputra Development, one of Indonesia's leading property companies with 75 projects spread across 33 cities, is increasingly focused on diversifying its portfolio outside the island of Java. The company has expanded to Sumatra, Kalimantan and Sulawesi as it wants to "bet on more than one horse" to improve its corporate earnings.

    Read column ›

  • Developing Upstream Facilities in Indonesia's Pharmaceutical Industry

    Vincent Harijanto, Head of the Indonesian Pharmaceutical Association (GP Farmasi) business development committee, said about 95 percent of raw materials used in Indonesia's pharmaceutical industry need to be imported from abroad. This dependence on imports causes several problems, for example prices of pharmaceutical products are relatively high on the Indonesian market, while Indonesian pharmaceutical companies (and Indonesian consumers) can suddenly face rising prices in times of rupiah depreciation.

    Read column ›

  • Portfolio Watch Indonesia: What about Nippon Indosari Corpindo?

    Over the past couple of weeks shares of Indonesia's largest bread products producer Nippon Indosari Corpindo have been recovering modestly after a severe plunge that occurred between mid-May and early July this year. On Monday (11/09) shares of the company were up 0.40 percent to IDR 1,250 a piece. So far this year, however, its shares have slid nearly 22 percent.

    Read column ›

  • Tropical Fruit in Indonesia: Eyeing Rising Domestic Output

    In the second half of 2017 the number of imported fruit in Indonesian supermarkets and markets has fallen rather drastically. This is mainly caused by Indonesian government regulation and performance. Firstly, the government has been eager to limit imports of tropical fruit (since 2012). Secondly, the Trade Ministry was slow in issuing import approval permits (in Indonesia: Surat Persetujuan Impor, or SPI). Hence, imports of foreign fruit tumbled.

    Read column ›


The views expressed in these business columns are the views of the authors or the interviewed persons only and therefore do not necessarily reflect the views of Indonesia Investments. The authors are free to ventilate their opinions about the Indonesian business climate. Facts presented in these columns are the result of the author's own research or indicated sources, read disclaimer
.